Hiroyuki Tanaka

1988–2025 年に発表

264
論文数
29,504
被引用数
94
h 指数
227
i10 指数

被引用数

Hiroyuki Tanaka の年別被引用数1978 年: 被引用 1 件1989 年: 被引用 1 件1994 年: 被引用 4 件1995 年: 被引用 3 件1996 年: 被引用 13 件1997 年: 被引用 18 件1998 年: 被引用 26 件1999 年: 被引用 14 件2000 年: 被引用 37 件2001 年: 被引用 67 件2002 年: 被引用 90 件2003 年: 被引用 98 件2004 年: 被引用 135 件2005 年: 被引用 120 件2006 年: 被引用 153 件2007 年: 被引用 199 件2008 年: 被引用 148 件2009 年: 被引用 159 件2010 年: 被引用 180 件2011 年: 被引用 196 件2012 年: 被引用 196 件2013 年: 被引用 216 件2014 年: 被引用 209 件2015 年: 被引用 238 件2016 年: 被引用 211 件2017 年: 被引用 228 件2018 年: 被引用 239 件2019 年: 被引用 574 件2020 年: 被引用 666 件2021 年: 被引用 644 件2022 年: 被引用 611 件2023 年: 被引用 385 件2024 年: 被引用 675 件2025 年: 被引用 273 件2026 年: 被引用 7 件1979〜1988 年は被引用が無いため表示していません1990〜1993 年は被引用が無いため表示していません

引用元

国・地域

この著者を引用した国・地域の世界地図アメリカ合衆国: 引用元論文 1,916 件、この内訳の 19.5%日本: 引用元論文 1,149 件、この内訳の 11.7%中国: 引用元論文 1,067 件、この内訳の 10.9%イギリス: 引用元論文 575 件、この内訳の 5.8%ドイツ: 引用元論文 461 件、この内訳の 4.7%イタリア: 引用元論文 434 件、この内訳の 4.4%カナダ: 引用元論文 322 件、この内訳の 3.3%フランス: 引用元論文 296 件、この内訳の 3%韓国: 引用元論文 272 件、この内訳の 2.8%オーストラリア: 引用元論文 216 件、この内訳の 2.2%オランダ: 引用元論文 211 件、この内訳の 2.1%インド: 引用元論文 202 件、この内訳の 2.1%
0%19.5%その他 27.5%

分野

  • Medicine51.7%
  • Biochemistry, Genetics and Molecular Biology17.3%
  • Engineering8.1%
  • Immunology and Microbiology7.1%
  • Agricultural and Biological Sciences3.5%
  • Neuroscience3%
  • その他9.3%

トピック

  • Coronary Interventions and Diagnostics2%
  • Asthma and respiratory diseases1.8%
  • Immune Response and Inflammation1.6%
  • Organic Light-Emitting Diodes Research1.5%
  • Parathyroid Disorders and Treatments1.3%
  • Luminescence and Fluorescent Materials1.2%
  • その他90.6%

共著者

全論文

検索で開く
  1. Comparison of Clopidogrel Monotherapy After 1 to 2 Months of Dual Antiplatelet Therapy With 12 Months of Dual Antiplatelet Therapy in Patients With Acute Coronary Syndrome

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Yoshihisa Nakagawa, Takeshi Kimura, STOPDAPT-2 ACS Investigators, Ken Kozuma, Keiichi Igarashi Hanaoka, Saori Tezuka, Yumika Fujino, Risa Kato, Masayo Kitamura, Miyuki Tsumori, Miya Hanazawa, Misato Yamauchi, Itsuki Yamazaki, Mitsugu Hirokami, Nobuko Makiguchi, Yoichi Nozaki, Hirofumi Tomita, Masahiro Yagi, Tatsuya Komaru, Motoaki Higuchi, Takaaki Isshiki, Takahide Kodama, Atsushi Tosaka, Itaru Takamisawa, Hiroyuki Tanaka, Yoshiki Hata, Ryuichi Kato, Yoshihiro J. Akashi, Kazuhiko Yumoto, Kengo Tsukahara, Junya Ako, Y Onishi, Hiroyasu Uzui, Toshiyuki Noda, Itsuo Morishima, Minoru Yamada, Ruka Yoshida, Susumu Suzuki, Takuya Maeda, Takashi Tanigawa, Kazuaki Kaitani, Shunzo Matsuoka, Masaharu Akao, Takafumi Yokomatsu, Moriaki Inoko, Tsukasa Inada, Takashi Morita, Gaku Nakazawa, Shozo Ishihara, Makoto Kinoshita, Takanori Kusuyama, Kiyonori Togi, Toshihiro Tamura, Takashi Akasaka, Isao Tabuchi, Yasuki Kihara, Hironori Ueda, Yusuke Katayama, Takatoshi Wakeyama, Takeo Kaneko, Tetsuzo Wakatsuki, Koichi Kishi, Masayuki Doi, Hideki Okayama, Nobuhiro Suematsu, Shujiro Inoue, Masahiro Natsuaki, Kenichi Tsujita, Tomohiro Sakamoto, Hirofumi Kurokawa ほか 2 名 - JAMA Cardiology 2022 被引用: 300

  2. Enzyme-linked immunosorbent assay for the quantitative/qualitative analysis of plant secondary metabolites

    著者: , , , , , , - Journal of Natural Medicines 2017 被引用: 594

  3. Burosumab versus conventional therapy in children with X-linked hypophosphataemia: a randomised, active-controlled, open-label, phase 3 trial

    著者: , , , , , , , , , , , , , , , , , , , , , , - The Lancet 2019 被引用: 367

  4. JCS/JSCS/JATS/JSVS 2020 Guidelines on the Management of Valvular Heart Disease

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Yutaka Okita, Takeshi Kimura, Yoshiki Sawa, Kiyoshi Yoshida, on behalf of the Japanese Circulation Society Joint Working Group - Circulation Journal 2020 被引用: 355

  5. A Randomized, Double-Blind, Placebo-Controlled, Phase 3 Trial Evaluating the Efficacy of Burosumab, an Anti-FGF23 Antibody, in Adults With X-Linked Hypophosphatemia: Week 24 Primary Analysis

    著者: , , , , , , , , , , , , , , , , , , , , , - Journal of Bone and Mineral Research 2018 被引用: 340

  6. The nuclear factor HMGB1 mediates hepatic injury after murine liver ischemia-reperfusion

    著者: , , , , , , , , , , - The Journal of Experimental Medicine 2005 被引用: 1,102

  7. Predicting Successful Guidewire Crossing Through Chronic Total Occlusion of Native Coronary Lesions Within 30 Minutes

    著者: , , , , , , , , , , , , , , , - JACC: Cardiovascular Interventions 2011 被引用: 883

  8. Artificial intelligence to diagnosis distal radius fracture using biplane plain X-rays

    著者: , , , , , - Journal of Orthopaedic Surgery and Research 2021 被引用: 45

  9. Periostin: A novel component of subepithelial fibrosis of bronchial asthma downstream of IL-4 and IL-13 signals

    著者: , , , , , , , , , - Journal of Allergy and Clinical Immunology 2006 被引用: 662

  10. Non-Driving Related tasks and journey types for future autonomous vehicle owners

    著者: , , , , - Transportation Research Part F Traffic Psychology and Behaviour 2022 被引用: 45

  11. Features and Outcomes of Histologically Proven Myocarditis With Fulminant Presentation

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Mitsunori Kamigaki, Hirofumi Tomita, Kenji Hanada, Motoi Kushibiki, Akihiro Nakamura, Yoshihiro Morino, Takahito Nasu, Satoshi Yasuda, Hideaki Suzuki, Kaoru Iwabuchi, Kanako Tsuji, Shigeto Namiuchi, Tatsuya Komaru, Masahiro Yagi, Shoko Uematsu, Toshiaki Takahashi, Satoru Takeda, Toru Nakanishi, Masafumi Watanabe, Masahiro Wanezaki, Motoyuki Matsui, Shigeo Sugawara, Yasuchika Takeishi, Masayoshi Oikawa, Nobuo Komatsu, Satoshi Suzuki, Hiroshi Okamoto, Noriyuki Takeyasu, Daiki Akiyama, Yutaka Eki, Tsunekazu Kakuta, Tomoyo Sugiyama, Tomomi Koizumi, Koji Ueno, Kazuomi Kario, Mizuri Taki, Yuri Matsumoto, Takanori Yasu, Osamu Nishioka, Shigeto Naito, Makoto Murata, Shoichi Tange, Katsumi Kaneko, Makoto Muto, Hiroshi Inagaki, Shuichi Hasegawa, Eizo Tachibana, Wataru Atsumi, Masahiro Suzuki, Toshihiro Muramatsu, Yoshihiro Yamada, Isao Taguchi, Yoshiaki Fukuda, Akihiro Matsui, Junji Kanda, Koji Hozawa, Akihiko Matsumura, Wataru Shimizu, Takeshi Yamamoto, Issei Komuro, Masaru Hatano, Takanori Ikeda, Shunsuke Kiuchi, Taishiro Chikamori, Yasuyoshi Takei, Kyoko Soejima, Toshinori Minamishima, Hiroyuki Tanaka, Shigeo Shimizu, Masashi Kasao ほか 259 名 - Circulation 2022 被引用: 59

  12. Efficient blue organic light-emitting diodes employing thermally activated delayed fluorescence

    著者: , , , , , - Nature Photonics 2014 被引用: 2,425

  13. Light Controls Protein Localization through Phytochrome-Mediated Alternative Promoter Selection

    著者: , , , , , , , , , , , , - Cell 2017 被引用: 163

  14. IL-4 as a Repurposed Biological Drug for Myocardial Infarction through Augmentation of Reparative Cardiac Macrophages: Proof-of-Concept Data in Mice

    著者: , , , , , , , , , - Scientific Reports 2017 被引用: 103

  15. Clinical Characteristics of Hospitalized Heart Failure Patients with Preserved, Mid-Range, and Reduced Ejection Fractions in Japan

    著者: , , , , , , , , , , , , , , , , , , , - ESC Heart Failure 2019 被引用: 123

  16. Prevalence, predictors, and outcomes of in-stent restenosis with calcified nodules

    著者: , , , , , , , , , , , - EuroIntervention 2022 被引用: 33

  17. Vitamin D Is an Important Factor in Estrogen Biosynthesis of Both Female and Male Gonads*

    著者: , , , , , - Endocrinology 2000 被引用: 521

  18. Low-density lipoprotein cholesterol targeting with pitavastatin + ezetimibe for patients with acute coronary syndrome and dyslipidaemia: the HIJ-PROPER study, a prospective, open-label, randomized trial

    著者: , , , , , , , , , , , , , - European Heart Journal 2017 被引用: 131

  19. Burosumab treatment in adults with X-linked hypophosphataemia: 96-week patient-reported outcomes and ambulatory function from a randomised phase 3 trial and open-label extension

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , - RMD Open 2021 被引用: 72

  20. Early Changes in Alpha-Fetoprotein Are a Useful Predictor of Efficacy of Atezolizumab plus Bevacizumab Treatment in Patients with Advanced Hepatocellular Carcinoma

    著者: , , , , , , , , , , , , , , - Oncology 2021 被引用: 43

  21. High-efficiency organic light-emitting diodes with fluorescent emitters

    著者: , , , , , , , , , - Nature Communications 2014 被引用: 1,183

  22. Prostaglandin D 2 as a Mediator of Allergic Asthma

    著者: , , , , , , , , , , , , , , , , , - Science 2000 被引用: 740

  23. Effectiveness of Paclitaxel-Eluting Balloon Catheter in Patients With Sirolimus-Eluting Stent Restenosis

    著者: , , , , , , , , , , , , , , , , , , , , , , , - JACC: Cardiovascular Interventions 2011 被引用: 281

  24. Factors Affecting Canagliflozin-Induced Transient Urine Volume Increase in Patients with Type 2 Diabetes Mellitus

    著者: , , , , , , , , , - Advances in Therapy 2016 被引用: 141